Source: Purinergic Signalling. Conference titles: International Basic and Translational Science on Purinergic Signaling and its Components for a Health and Better World/PURINES. Unidade: IQ
Subjects: MELANOMA, ENZIMAS, VITAMINA D
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAGATINI, M. D et al. 1α,25-dihydroxyvitamin D3 alters ectonucleotidase expression and activity in human cutaneous melanoma cells. Purinergic Signalling. Dordrecht: Instituto de Química, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s11302-018-9637-0. Acesso em: 06 out. 2024. , 2019APA
Bagatini, M. D., Bertolin, K., Bridi, A., Pelison, L. P., Bonadiman, B. S. R., Pillat, M. M., et al. (2019). 1α,25-dihydroxyvitamin D3 alters ectonucleotidase expression and activity in human cutaneous melanoma cells. Purinergic Signalling. Dordrecht: Instituto de Química, Universidade de São Paulo. doi:10.1007/s11302-018-9637-0NLM
Bagatini MD, Bertolin K, Bridi A, Pelison LP, Bonadiman BSR, Pillat MM, Gonçalves PBD, Ulrich H, Schetinger MRC, Morsch VMM. 1α,25-dihydroxyvitamin D3 alters ectonucleotidase expression and activity in human cutaneous melanoma cells [Internet]. Purinergic Signalling. 2019 ; 14 S109.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s11302-018-9637-0Vancouver
Bagatini MD, Bertolin K, Bridi A, Pelison LP, Bonadiman BSR, Pillat MM, Gonçalves PBD, Ulrich H, Schetinger MRC, Morsch VMM. 1α,25-dihydroxyvitamin D3 alters ectonucleotidase expression and activity in human cutaneous melanoma cells [Internet]. Purinergic Signalling. 2019 ; 14 S109.[citado 2024 out. 06 ] Available from: https://doi.org/10.1007/s11302-018-9637-0